Bioceres Crop Solutions Corp.
BIOX
$4.47
-$0.02-0.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 383.29M | 407.73M | 441.27M | 464.83M | 445.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 383.29M | 407.73M | 441.27M | 464.83M | 445.59M |
| Cost of Revenue | 233.46M | 238.31M | 265.30M | 283.24M | 271.99M |
| Gross Profit | 149.83M | 169.42M | 175.96M | 181.59M | 173.60M |
| SG&A Expenses | 103.13M | 103.49M | 102.26M | 106.97M | 106.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.16M | 16.04M | 16.98M | 17.00M | 15.72M |
| Total Operating Expenses | 361.00M | 375.02M | 401.33M | 424.06M | 409.55M |
| Operating Income | 22.29M | 32.71M | 39.94M | 40.77M | 36.04M |
| Income Before Tax | -18.76M | -4.35M | 4.82M | 10.04M | 11.78M |
| Income Tax Expenses | -9.50M | -6.45M | 2.08M | 3.78M | 6.23M |
| Earnings from Continuing Operations | -9.26 | 2.10 | 2.74 | 6.26 | 5.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 204.20K | -603.00K | -1.27M | -3.01M | -2.48M |
| Net Income | -9.06M | 1.50M | 1.47M | 3.24M | 3.07M |
| EBIT | 22.29M | 32.71M | 39.94M | 40.77M | 36.04M |
| EBITDA | 40.87M | 50.89M | 57.92M | 57.98M | 51.79M |
| EPS Basic | -0.14 | 0.02 | 0.02 | 0.05 | 0.05 |
| Normalized Basic EPS | -0.18 | -0.05 | 0.03 | 0.05 | 0.08 |
| EPS Diluted | -0.14 | 0.02 | 0.01 | 0.04 | 0.04 |
| Normalized Diluted EPS | -0.18 | -0.06 | 0.02 | 0.05 | 0.07 |
| Average Basic Shares Outstanding | 251.26M | 251.31M | 251.33M | 251.32M | 250.67M |
| Average Diluted Shares Outstanding | 252.61M | 256.58M | 257.29M | 257.29M | 255.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |